THIRD AMENDMENT TO THE SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT

EX-4.11 3 dex411.htm THIRD AMENDMENT TO SECOND AMENDED AND RESTATED STOCKHOLDERS' AGREEMENT Third Amendment to Second Amended and Restated Stockholders' Agreement

EXHIBIT 4.11

THIRD AMENDMENT TO THE

SECOND AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT

THIS THIRD AMENDMENT (the “Amendment”) TO THE SECOND AMENDED AND RESTATED STOCKHOLDERS’ AGREEMENT dated as of August 4, 2004, as amended (the “Stockholders’ Agreement”), is entered into as of June 1, 2006 by and among Pharmasset, Inc., a Delaware corporation (the “Company”), and the undersigned holders of the Company’s capital stock (collectively, the “Stockholders”). Capitalized terms used but not otherwise defined in this Amendment shall have the meanings set forth in the Stockholders’ Agreement.

RECITALS

WHEREAS, the Board of Directors of the Company has approved an amendment to the Company’s Equity Incentive Plan, which increases the number of shares available for grants by 1,600,000 additional shares of the Company’s Common Stock from 3,675,522 to 5,275,522 shares;

WHEREAS, a same increase is being made concurrently to the number of shares of Common Stock set forth in clause (ii) of the definition of “Excluded Securities” in the Certificate of Incorporation;

WHEREAS, the Company and the Stockholders desire to amend the definition of “New Shares” set forth in Section 1.1 of the Stockholders’ Agreement;

NOW, THEREFORE, in consideration of the mutual promises and covenants hereinafter set forth, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree to amend the Stockholders’ Agreement as follows:

Definition. (a) The definition of the term “New Shares” set forth in Section 1.1 of the Stockholders’ Agreement is hereby amended by deleting clause (iii) thereof and replacing it in its entirety with the following:

“(iii) up to 5,275,522 shares of Common Stock (appropriately adjusted to take account of any stock split, stock dividend, combination of shares, recapitalization or other similar event) issuable to officers, directors, employees and consultants of the Company or a subsidiary pursuant to the exercise of options granted or shares of Common Stock directly issued under the Equity Incentive Plan, subject to vesting, and such options and other rights to acquire Common Stock granted thereunder;”

Governing Law. This Amendment shall be governed by and construed under the laws of the State of Delaware (without giving effect to any conflicts or choice of laws provisions which would cause the application of the domestic substantive laws of any other jurisdiction).


Effective Date. This Amendment shall become effective as of the date first written above (the “Effective Date”) upon receipt by the Company of counterparts of this Amendment duly executed by (i) the Majority Investors and (ii) the Stockholders holding a majority of the outstanding shares of the Common Stock that are subject to this Agreement and the Preferred Stock (on an as-if-converted basis) owned by such Stockholders. Each Stockholder shall be bound by this Amendment whether or not such Stockholder shall have consented to this Amendment.

Miscellaneous. From and after the Effective Date of this Amendment, each reference in the Stockholders’ Agreement to “this Agreement”, “hereof”, “hereunder”, or words of like import in any and all agreements, instruments, documents, notes, certificates and other writings of any kind and nature shall be deemed to refer to the Stockholders’ Agreement as amended by this Amendment. This Amendment may be executed in any number of counterparts, each of which shall be an original, but all of which together constitute one instrument. The headings in this Amendment are for purposes of reference only and shall not limit or otherwise effect the meaning hereof.

[Signatures on Following Pages]

 

2


IN WITNESS WHEREOF, the parties hereto have executed this Third Amendment to the Second Amended and Restated Stockholders’ Agreement as of the date set forth in the first paragraph hereof.

 

COMPANY:

 

PHARMASSET, INC.

    STOCKHOLDERS:
      /s/ Raymond F. Schinazi, Ph.D.
      Raymond F. Schinazi, Ph.D.
By:   /s/ P. Schaefer Price      
Name:   P. Schaefer Price      
Title:   President and Chief Executive Officer      
      RFS PARTNERS, L.P.
      By:   RFS & Associates, LLC
       
      By:   /s/ Raymond F. Schinazi
      Name:   Raymond F. Schinazi
      Title:   Manager
     

RAYMOND F. SCHINAZI 2005

QUALIFIED ANNUITY TRUST

       
      By:   /s/ Raymond F. Schinazi
      Name:   Raymond F. Schinazi
      Title:   Trustee
      /s/ Chung K. Chu, Ph.D.
      Chung K. Chu, Ph.D.
      IDENIX PHARMACEUTICALS, INC.
       
      By:     
      Name:  
      Title:  
       
       
       
        
      Dennis Liotta, Ph.D.
       
       
      /s/ Jean-Pierre Sommadossi, Ph.D.
      Jean-Pierre Sommadossi, Ph.D.

 

Signature Page to Third Amendment to

Second Amended and Restated Stockholders’ Agreement


      STOCKHOLDERS (Cont’d):
       
     

JEAN-PIERRE SOMMADOSSI 2004

QUALIFIED ANNUITY TRUST NO. 2

       
      By:   /s/ Jean-Pierre Sommadossi, Ph.D.
      Name:   Jean-Pierre Sommadossi, Ph.D.
      Title:   Trustee
      /s/ Carol Lynn Schinazi
      Carol Lynn Schinazi
        
      Rebecca Elizabeth Schinazi
      /s/ Jaime L. Rabi
      Jaime L. Rabi
        
      Jaclyn H. Chu
      /s/ Susan Chu Walley
      Susan Chu Walley
     
      HOFFMANN-LA ROCHE INC.
      By:   /s/ Frederick C. Kentz, III
      Name:   Frederick C. Kentz, III
      Title:   Vice President & General Counsel

 

Signature Page to Third Amendment to

Second Amended and Restated Stockholders’ Agreement


      STOCKHOLDERS (Cont’d):
       
     

BURRILL LIFE SCIENCES

CAPITAL FUND, L.P.

       
     

By: Burrill & Company (Life Sciences GP),

LLC, its General Partner

       
      By:   /s/ G. Steven Burrill
      Name:   G. Steven Burrill
      Title:   CEO
     

BURRILL INDIANA LIFE SCIENCES

CAPITAL FUND, L.P.

       
     

By: Burrill and Company (Indiana GP),

LLC, its General Partner

       
      By:   /s/ G. Steven Burrill
      Name:   G. Steven Burrill
      Title:   CEO
      MPM BIOVENTURES III, L.P.
       
     

By: MPM BioVentures III GP, L.P., its

General Partner

       
     

By: MPM BioVentures III LLC, its

General Partner

       
      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  

 

Signature Page to Third Amendment to

Second Amended and Restated Stockholders’ Agreement


      STOCKHOLDERS (Cont’d):
       
      BB BIOVENTURES L.P.
       
      By:  

BAB BioVentures L.P., its

General Partner

       
      By:  

BAB BioVentures, N.V., its

General Partner

       
      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  
     

MPM BIOVENTURES PARALLEL

FUND, L.P.

       
      By:  

MPM BioVentures I LP, its

General Partner

       
      By:  

MPM BioVentures I LLC, its

General Partner

       
      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  
     

MPM ASSET MANAGEMENT

INVESTORS 1999 LLC

       
      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  
      MPM BIOVENTURES III-QP, L.P.
       
     

By: MPM BioVentures III GP, L.P., its

General Partner

       
     

By: MPM BioVentures III LLC, its

General Partner

      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  

 

Signature Page to Third Amendment to

Second Amended and Restated Stockholders’ Agreement


      STOCKHOLDERS (Cont’d):
       
     

MPM BIOVENTURES III GMBH & CO.

BETEILIGUNGS KG

       
     

By: MPM BioVentures III GP, L.P., in its

capacity as the Managing Limited Partner

       
     

By: MPM BioVentures III LLC, its

General Partner

       
      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  
     

MPM BIOVENTURES III PARALLEL

FUND, L.P.

       
     

By: MPM BioVentures III GP, L.P., its

General Partner

       
     

By: MPM BioVentures III LLC, its

General Partner

       
      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  
     

MPM ASSET MANAGEMENT

INVESTORS 2004 BVIII LLC

       
      By:   /s/ Ansbert Gädicke
      Name:  
      Title:  

 

Signature Page to Third Amendment to

Second Amended and Restated Stockholders’ Agreement


      STOCKHOLDERS (Cont’d):
       
     

TVM V LIFE SCIENCE VENTURES

GMBH & CO. KG

       
      By:   /s/ John J. Dibello
      Name:   John J. Dibello
      Title:   Managing Limited Partner
       
      By:   /s/ David Poltack
      Name:   David Poltack
      Title:   Managing Limited Partner
      TVM IV GMBH & CO. KG
       
      By:   /s/ John J. Dibello
      Name:   John J. Dibello
      Title:   Managing Limited Partner
       
      By:   /s/ David Poltack
      Name:   David Poltack
      Title:   Managing Limited Partner
     

MDS LIFE SCIENCES TECHNOLOGY

FUND II NC LIMITED PARTNERSHIP

       
     

By: MDS LSTF II (NCGP) Inc., its

General Partner

      By:     
      Name:  
      Title:  
     

MDS LIFE SCIENCES TECHNOLOGY

FUND II QUEBEC LIMITED

PARTNERSHIP

       
     

By: MDS LSTF II (QGP) Inc., its

General Partner

      By:     
      Name:  
      Title:  

 

Signature Page to Third Amendment to

Second Amended and Restated Stockholders’ Agreement


      STOCKHOLDERS (Cont’d):
       
     

MLII CO-INVESTMENT FUND NC

LIMITED PARTNERSHIP

       
     

By: MLII (NCGP) Inc., its

General Partner

      By:     
      Name:  
      Title:  
      CDIB BIOSCIENCE VENTURES I, INC.
       
      By:   Benny T. Hu
      Name:   Benny T. Hu
      Title:   Chairman

 

Signature Page to Third Amendment to

Second Amended and Restated Stockholders’ Agreement